CDK2阻害剤

JP7892011B2Active Publication Date: 2026-07-17BLUEPRINT MEDICINES CORP
View PDF 6 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
BLUEPRINT MEDICINES CORP
Filing Date
2022-06-27
Publication Date
2026-07-17

Smart Images

  • Figure 0007892011000001
    Figure 0007892011000001
  • Figure 0007892011000002
    Figure 0007892011000002
  • Figure 0007892011000003
    Figure 0007892011000003
Patent Text Reader

Abstract

The present disclosure provides compounds of structural formula (I): The present invention provides a compound useful for treating cancer, represented by TIFF2024524373000349.tif50165, or a pharma- ceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art